3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous-Cell Lung Cancer
1
Small Cell Lung Carcinoma
1
Retinoblastoma
1
Retinal Neoplasms
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Bronchogenic
1
Bronchial Neoplasms
1
Advanced Non Small Cell Lung Cancer
1
Adenocarcinoma of Lung
1
Interventions
Etoposide
2
Carboplatin
2
Vincristine
1
Platinum Compounds
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Drug Therapy
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Retinal Neoplasms
×
Platinum Compounds
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled